NSEAnalysts/Institutional Investor Meet/Con. Call Updates26 Oct 2026 · 26 Oct 2026, 04:40 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Marksans Pharma Limited · MARKSANS

✦ AI SummaryResults

Marksans Pharma Limited has scheduled a conference call on November 05, 2026, to discuss its unaudited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Marksans Pharma Limited has informed the Exchange about Schedule for Q2FY27 Earnings Conference Call

Attachments (1)

📄

MARKSANS_26102026164015_Seintimation.pdf

pdf

Download →
View document text
October 26, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai – 400001. Bandra (East), Mumbai – 400051. Scrip Code: 524404 Symbol: MARKSANS Subject: Intimation of schedule for Q2FY27 Earnings Conference Call Dear Sir/Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled a conference call for analysts and investors on Thursday, November 05, 2026 at 04:00 PM (IST) to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. The details and schedule with respect to the conference call are enclosed herewith. The presentation along with the audio recording of the call and the transcript will be hosted on the Company’s website at https://www.marksanspharma.com/earnings-call-transcripts.html We request you to take the aforesaid on your records. Thanking you. Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Encl: As below Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com SYSTEMATIX INSTITUTIONAL EQUITIES Invites you to participate in Q2FY27 Results Conference Call of Marksans Pharma Limited On Thursday, 5th November 2026 at 4:00 PM (IST) The management will be represented by Mr. Mark Saldanha Mr. Jitendra Sharma Founder, Chairman, and Managing Director Chief Financial Officer Dial-in-number Location Dial Number Location Toll Free Number USA : 1 866 746 2133 Primary Number +91 22 6280 1297 UK : 0 808 101 1573 Singapore : 800 101 2045 Secondary Number +91 22 7115 8198 Hong Kong : 800 964 448 Click here for your Diamond Pass™ https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=4215452&linkSecurityString=254ce79eb0 DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator. For more information, please contact: Vishal Manchanda Mrunal Pawar Equity Research Analyst Senior VP & Group Head - Corporate Access & Contact No: +91 97374 37148 Corporate Communication vishalmanchanda@systematixgroup.in Contact No: + 91 22 6704 8088 mrunalpawar@systematixgroup.in